Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial
Open Access
- 24 January 2022
- journal article
- research article
- Published by Elsevier BV in EClinicalMedicine
- Vol. 44, 101274
- https://doi.org/10.1016/j.eclinm.2022.101274
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Contemporary Outcome Measures in Acute Stroke ResearchStroke, 2012
- Calculation of Numbers-Needed-To-Treat in Parallel Group Trials Assessing Ordinal Outcomes: Case Examples from Acute Stroke and Stroke PreventionInternational Journal of Stroke, 2011
- Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trialThe Lancet Neurology, 2010
- Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in Acute StrokeJournal of Stroke and Cerebrovascular Diseases, 2009
- A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and FeasibilityPLOS ONE, 2008
- Glyceryl Trinitrate vs. Control, and Continuing vs. Stopping Temporarily Prior Antihypertensive Therapy, in Acute Stroke: Rationale and Design of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial (ISRCTN99414122)International Journal of Stroke, 2006
- Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular EventsStroke, 2003
- A trial of blood pressure reduction in acute strokeAge and Ageing, 2000
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionThe Lancet, 1991
- A Self-Rating Depression ScaleArchives of General Psychiatry, 1965